Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosis
US11905336B2 · kind B2 · utility
0Cited by
44References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 10, 2019 |
| Grant date | Feb 20, 2024 |
| Priority date | — |
| Expiry date | Sep 10, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compositions comprising modified caveolin-1 (Cav-1) peptides. Further provided are methods of using the modified Cav-1 peptides for the treatment of lung infections or acute or chronic lung injury, particularly lung fibrosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.